| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone acetate |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone measurement |
Component |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone adverse reaction |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Topical dexamethasone adverse reaction |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Topical compound dexamethasone preparation adverse reaction |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dexamethasone |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Topical dexamethasone allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Topical compound dexamethasone preparation allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone overdose |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Accidental dexamethasone overdose |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Intentional dexamethasone overdose |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| surdose de dexaméthasone d'intention indéterminée |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 100 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 2mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 2mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 10mg/25g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 0.5mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone + neomycin sulfate 1mg/3.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone + tobramycin 0.1%wv/0.3%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone + tobramycin 1mg/3mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate 24mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate 4mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone ophthalmic preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone nasal preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Desoximetasone (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone phosphate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone-21-isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone+hypromellose 0.1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 0.1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Topical form compound dexamethasone preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone compound eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone sodium phospha 1mg/cc solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| médicament contenant dexaméthasone et néomycine et polymyxine B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Tramazoline hydrochloride+dexamethasone isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing ciprofloxacin and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 700 microgram prolonged-release ocular implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Topical compound dexamethasone preparation allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dexamethasone |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Topical dexamethasone allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone sodium metasulfobenzoate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium metasulfobenzoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone isonicotinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 100 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]